New FDA guidance on the use of Bayesian statistics signals a broader shift in accommodating more flexible clinical trial ...
The US Food and Drug Administration (FDA) recently highlighted three case studies showing how sponsors can incorporate innovative study designs in their clinical trials using the agency’s Complex ...
Industry groups and drugmakers want the US Food and Drug Administration (FDA) to explicitly clarify that Bayesian statistical methods can be used for products beyond those intended for children and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results